Progress of external beam radiotherapy for thyroid cancer

doi:10.3760/cma.j.issn.1673-422X.2019.11.001

Journal of International Oncology ›› 2019, Vol. 46 ›› Issue (11): 641-648.doi: 10.3760/cma.j.issn.1673-422X.2019.11.001

Progress of external beam radiotherapy for thyroid cancer

Dong Fang1, Xue Jincai2, Wang Yunsheng2, Liu Qinjiang2

1Department of Radiation Oncology, Gansu Province Tumor Hospital, Lanzhou 730050, China; 2Department of Head and Neck Surgery, Gansu Province Tumor Hospital, Lanzhou 730050, China

Online:2019-11-08 Published:2019-11-08
Contact: Liu Qinjiang E-mail:liuqj99@126.com
Supported by:
Science and Technology Development Program of Lanzhou (2017-4-75); Science and Technology Program of Lanzhou (2018-3-38)

Abstract

Abstract: External beam radiotherapy (EBRT) is one of the important treatment of thyroid cancer. EBRT is still controversial in some aspects of differentiated thyroid cancer. With the development of radiotherapy technology, improvement of equipment and accuracy, treatment complications caused by EBRT are significantly reduced. As a result, EBRT is valued again in the treatment of thyroid cancer, and its indications have been broadened. How to improve the curative effect and guarantee the quality of life becomes the focus of attention. EBRT may be an effective treatment for specific stage and pathological type of thyroid cancer. The multidisciplinary approach is expected to benefit more patients in the future.

Key words: Thyroid neoplasms, Antineoplastic protocols, Radiotherapy

Dong Fang, Xue Jincai, Wang Yunsheng, Liu Qinjiang. Progress of external beam radiotherapy for thyroid cancer[J]. Journal of International Oncology, 2019, 46(11): 641-648.

[1]	Qian Xiaotao, Shi Ziyi, Hu Ge, Wu Xiaowei. Efficacy of consolidation chemotherapy after radical radiotherapy and chemotherapy for stage Ⅲ-ⅣA esophageal squamous cell carcinoma： a real-world clinical study [J]. Journal of International Oncology, 2024, 51(6): 326-331.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun. Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer [J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu. Research progress on intestinal flora and non-surgical treatment of the colorectal cancer [J]. Journal of International Oncology, 2024, 51(6): 376-381.
[4]	Wang Zihao, Wang Yu, Yang Xin, He Yi, Mo Xingkui, Yuan Tao. Research progress on the molecular mechanism and related treatments of ferroptosis in osteosarcoma [J]. Journal of International Oncology, 2024, 51(4): 239-244.
[5]	Qian Xiaotao, Shi Ziyi, Hu Ge. A real-world clinical study of immunocheckpoint inhibitor maintenance therapy after radical radiotherapy and chemotherapy in stage Ⅲ-ⅣA esophageal squamous cell carcinoma [J]. Journal of International Oncology, 2024, 51(3): 151-156.
[6]	Li Shuyue, Ma Chenying, Zhou Juying, Xu Xiaoting, Qin Songbing. Progress of radiotherapy in oligometastatic non-small cell lung cancer [J]. Journal of International Oncology, 2024, 51(3): 170-174.
[7]	Gao Xinyu, Li Zhenjiang, Sun Hongfu, Han Dan, Zhao Qian, Liu Chengxin, Huang Wei. Clinical application of MR-guided radiotherapy based on MR-linac in esophageal cancer patients [J]. Journal of International Oncology, 2024, 51(1): 37-42.
[8]	Cui Tenglu, Lyu lu, Sun Pengfei. Application of radiotherapy combined with immunotherapy in the treatment of head and neck squamous cell carcinoma [J]. Journal of International Oncology, 2023, 50(9): 548-552.
[9]	Zhang Jinnan, Liu Bangqing, Li Jun, Liu Xiaohui. Research on BHLHE40 targets HMGA2 to reduce the sensitivity of thyroid cancer cells to cisplatin through activating the oxidative phosphorylation pathway [J]. Journal of International Oncology, 2023, 50(7): 398-406.
[10]	Li Qingshan, Xie Xin, Zhang Nan, Liu Shuai. Research progress on the application of combining radiotherapy and systemic therapy in breast cancer [J]. Journal of International Oncology, 2023, 50(6): 362-367.
[11]	Lyu Lu, Sun Pengfei. Gut flora and cervical cancer [J]. Journal of International Oncology, 2023, 50(6): 373-376.
[12]	Radiation Oncology Treatment Physician Branch, Chinese Medical Doctor Association, Radiation Oncology Therapy Branch, Chinese Medical Association, Chinese Association of Radiation Therapy, China Anti-Cancer Association. Chinese experts' consensus on the application of pegylated recombinant human granulocyte colony-stimulating factor during concurrent chemoradiotherapy （2023 version） [J]. Journal of International Oncology, 2023, 50(4): 193-201.
[13]	Xu Meng, Jiang Wei, Zhu Haitao, Cao Xiongfeng. Research progress of cancer-associated fibroblasts in tumor radiotherapy resistance [J]. Journal of International Oncology, 2023, 50(4): 227-230.
[14]	Shi Xaioqi, Wang Hongyan. Research progress on the interaction between gut microbiota and radiation enteritis [J]. Journal of International Oncology, 2023, 50(4): 244-247.
[15]	Zhao Yongrui, Gao Ying, Chen Yidong, Xu Jiankun. Efficacy and safety of linear accelerator-based fractionated stereotactic radiotherapy for small volume brain metastases [J]. Journal of International Oncology, 2023, 50(3): 138-143.

Progress of external beam radiotherapy for thyroid cancer

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments